1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New Jersey >
  6. QuidelOrtho Acquires Ortho Clinical Diagnostics

M&A Deal Summary

QuidelOrtho Acquires Ortho Clinical Diagnostics

On December 23, 2021, QuidelOrtho acquired medical products company Ortho Clinical Diagnostics for 6.0B USD

Acquisition Highlights
  • This is QuidelOrtho’s 1st transaction in the Medical Products sector.
  • This is QuidelOrtho’s largest (disclosed) transaction.
  • This is QuidelOrtho’s 4th transaction in the United States.
  • This is QuidelOrtho’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2021-12-23
Target Ortho Clinical Diagnostics
Sector Medical Products
Buyer(s) QuidelOrtho
Deal Type Add-on Acquisition
Deal Value 6.0B USD
Advisor(s) J.P. Morgan Securities (Financial)
Latham & Watkins (Legal)

Target

Ortho Clinical Diagnostics

Raritan, New Jersey, United States
Ortho Clinical Diagnostics is a provider of vitro diagnostic products. The company serves the global transfusion medicine community with donor screening and blood typing products to help ensure every patient receives blood that is safe, the right type and the right unit. Ortho Clinical Diagnostics was founded in 1939 and is based in Raritan, New Jersey.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

QuidelOrtho

San Diego, California, United States
Category Company
Founded 1979
Sector Healthcare Services
Employees7,100
Revenue 2.8B USD (2024)
DESCRIPTION

QuidelOrtho develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, women?s health, and gastrointestinal diseases. QuidelOrtho was founded in 1979 and is based in San Diego, California.

DEAL STATS #
Overall 4 of 4
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 2
State: New Jersey M&A 1 of 1
Country: United States M&A 4 of 4
Year: 2021 M&A 1 of 1
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-07-17 Alere - Triage Assets

Waltham, Massachusetts, United States

Alere, Inc. - Triage Assets includes MeterPro cardiovascular (CV) and toxicology assets (“Triage business”) and the B-type Naturietic Peptide (BNP) assay business run on Beckman Coulter analyzers (“BNP business”).

Buy -
Mergr

Solution for

Product

Company

Legal